TY - JOUR
T1 - Gastrointestinal stromal sarcomas
AU - Lev, D.
AU - Kariv, Y.
AU - Issakov, J.
AU - Merhav, H.
AU - Berger, E.
AU - Merimsky, O.
AU - Klausner, J. M.
AU - Gutman, M.
PY - 1999
Y1 - 1999
N2 - Background: Gastrointestinal stromal sarcomas are a rare group of malignancies originating in the bowel wall. Methods: The treatment of 12 patients with gastrointestinal stromal sarcoma who underwent operation between 1994 and 1998 was reviewed. Results: Eight tumours originated in the stomach; others were in the small bowel or rectum. Five of the tumours were of myogenic origin, two were gastrointestinal autonomic nerve tumours, one was a mixed neural-myoid tumour, and four could not be differentiated. Complete resection was possible in ten patients; in two of the ten en bloc resection of adjacent organs was required to ensure adequate margins. The tumours in the remaining two patients were irresectable because of diffuse intra-abdominal metastatic disease. All patients who underwent complete resection were alive after 4-48 (median 14) months. Two of the ten patients developed recurrence, which was reresected completely. The patients with metastatic disease died less than 1 year after operation. Conclusion: Aggressive surgical resection, achieving complete resection, can lead to prolongation of life and may be a potential cure for patients with gastrointestinal stromal sarcoma.
AB - Background: Gastrointestinal stromal sarcomas are a rare group of malignancies originating in the bowel wall. Methods: The treatment of 12 patients with gastrointestinal stromal sarcoma who underwent operation between 1994 and 1998 was reviewed. Results: Eight tumours originated in the stomach; others were in the small bowel or rectum. Five of the tumours were of myogenic origin, two were gastrointestinal autonomic nerve tumours, one was a mixed neural-myoid tumour, and four could not be differentiated. Complete resection was possible in ten patients; in two of the ten en bloc resection of adjacent organs was required to ensure adequate margins. The tumours in the remaining two patients were irresectable because of diffuse intra-abdominal metastatic disease. All patients who underwent complete resection were alive after 4-48 (median 14) months. Two of the ten patients developed recurrence, which was reresected completely. The patients with metastatic disease died less than 1 year after operation. Conclusion: Aggressive surgical resection, achieving complete resection, can lead to prolongation of life and may be a potential cure for patients with gastrointestinal stromal sarcoma.
UR - http://www.scopus.com/inward/record.url?scp=0032957021&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2168.1999.01075.x
DO - 10.1046/j.1365-2168.1999.01075.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0032957021
VL - 86
SP - 545
EP - 549
JO - British Journal of Surgery
JF - British Journal of Surgery
SN - 0007-1323
IS - 4
ER -